×

Cancer gene determination and therapeutic screening using signature gene sets

  • US 20040115625A1
  • Filed: 10/02/2001
  • Published: 06/17/2004
  • Est. Priority Date: 10/02/2000
  • Status: Abandoned Application
First Claim
Patent Images

1. A process for identifying an agent that modulates the activity of a cancer-related gene comprising:

  • (a) contacting a compound with a cell containing a gene that corresponds to a polynucleotide having a sequence selected from the group consisting of SEQ ID NO;

    1-1001 and under conditions promoting the expression of said gene; and

    (b) detecting a difference in expression of said gene relative to when said compound is not present thereby identifying an agent that modulates the activity of a cancer-related gene.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×